000 01282nam  2200253za 4500
0019.629954
003CaOODSP
00520221107134256
007cr |||||||||||
008150407s2015||||xxc|||||o    f|0| 0 eng d
020 |a978-1-100-25790-7
040 |aCaOODSP|beng
043 |an-cn---
0861 |aHP40-135/2015E-PDF
1102 |aPublic Health Agency of Canada.
24510|aRe-immunization with polysaccharide 23-valent pneumococcal vaccine (Pneu-P-23) |h[electronic resource]
2461 |iAt head of title: |aAdvisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI)
260 |aOttawa : |bPublic Health Agency of Canada, |cApril 2015.
300 |a28 p. : |btables.
500 |aAlso available in French under title: Une déclaration d’un comité consultatif (DCC), Comité consultatif national de l’immunisation (CCNI) : revaccination avec le vaccin polysaccharidique 23-valent contre le pneumocoque (Pneu-P-23).
504 |aIncludes bibliographical references.
69007|aImmunization|2gcpds
77508|tRevaccination avec le vaccin polysaccharidique 23-valent contre le pneumocoque (Pneu-P-23)|w(CaOODSP)9.677547
85640|qPDF|s1.13 MB|uhttps://publications.gc.ca/collections/collection_2015/aspc-phac/HP40-135-2015-eng.pdf